Viral vector production system
AssigneeOxford Biomedica (UK) Limited
InventorsDaniel Farley, Kyriacos Mitrophanous
Life of this patent
Estimating the term…
Loading patent…
AssigneeOxford Biomedica (UK) Limited
InventorsDaniel Farley, Kyriacos Mitrophanous
Estimating the term…
Disclosed herein are viral vector production systems secreting nuclease for degradation of residual nucleic acid during viral vector production and methods of the same. Such a viral vector production system comprises a viral vector production cell comprising nucleic acid sequences encoding: 1) viral vector components; and 2) a nuclease, wherein the nuclease is expressed in the production cell and secreted in cell culture thereby degrading residual nucleic acid during viral vector production. Another such viral vector production system comprises 1) a viral vector production cell comprising nucleic acid sequences encoding viral vector components; and 2) a nuclease helper cell comprising a nucleic acid sequence encoding a nuclease, wherein the nuclease is expressed and secreted in co-culture of the production cell of 1) and the helper cell of 2), thereby degrading residual nucleic acid during viral vector production.
A viral vector production system comprising a viral vector production cell comprising nucleic acid sequences encoding:
A viral vector production system comprising:
A method of producing a viral vector, the method comprising, transfecting a viral vector production cell with nucleic acid sequences encoding:
A method of producing a viral vector, the method comprising contacting 1) a viral vector production cell expressing viral vector components with 2) a nuclease helper cell expressing a nuclease, wherein the nuclease is expressed in the helper cell and secreted in co-culture of the production cell with the helper cell thereby degrading residual nucleic acid during viral vector production.
A method of producing a viral vector, the method comprising contacting 1) a viral vector production cell expressing viral vector components with 2) a liquid feed from nuclease helper cell expressing a nuclease, wherein the nuclease is expressed in the cell and secreted in cell culture thereby degrading residual nucleic acid during viral vector production.
In an improved method of producing a viral vector, the improvement comprising introducing nucleic acid sequences into a viral vector production cell, wherein the nucleic acid sequences encode:
In an improved method of producing a viral vector, the improvement comprising contacting in co-culture a viral vector production cell expressing viral vector components with a nuclease helper cell expressing a nuclease, wherein the nuclease is expressed in the production cell and secreted in cell culture thereby degrading residual nucleic acid during viral vector production.
(canceled)
(canceled)
11-13. (canceled)
15-31. (canceled)
(canceled)
36-41. (canceled)
A production cell for producing viral vectors comprising nucleic acid sequences encoding:
45-51. (canceled)
A production cell for producing viral vectors comprising nucleic acid sequences encoding:
(canceled)
A cell culture device comprising a viral vector production system comprising a viral vector production cell comprising nucleic acid sequences encoding:
(canceled)
A variant of a secreted nuclease capable of degrading residual nucleic acid during viral vector production, said variant comprising the amino acid sequence of SEQ ID NO:
A modified nuclease having increased cell-retention and/or or cell-association that is expressed through the secretory pathway of a eukaryotic cell, wherein the modified nuclease comprises a retention signal at its C-terminus.
59-71. (canceled)
73-76. (canceled)
A nuclease helper cell wherein secreted nuclease activity within the helper cell culture is at least about 10 unit per mL of equivalent Benzonase® nuclease activity as determinable by the assay presented as Assay 1 herein.
78-82. (canceled)
Dependencies are inferred from the claim text.